Una vacuna no bastará para combatir el covid, dice jefe de Novartis
CEO of Novartis pinning hopes on malaria drug - Basel Area Business & Innovation
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Vasant Narasimhan | Novartis
Es demasiado pronto para declarar al Covid endémico, dice el CEO de Novartis Narasimhan - Salud News
Un médico para Novartis | Economía | EL PAÍS
Novartis continúa la transformación en una empresa líder de medicamentos
تويتر \ Novartis على تويتر: "Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I"
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
El antiviral de Novartis reduce un 78% el ingreso por covid
El director ejecutivo, Vas Narasimhan, del fabricante suizo de drogas Novartis, se dirige a la conferencia de prensa anual de la compañía en Basilea, Suiza, el 30 de enero de 2019. REUTERS/Arnd
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
21 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes
Novartis CEO Vas Narasimhan urges global push for free and open movement of trade and talent - The Hindu BusinessLine
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
Is Covid over? At HTLS, Novartis CEO Narasimhan says 'let society move forward' | Latest News India - Hindustan Times
Basel is very open to newcomers - Basel Area Business & Innovation
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
